B chronic lymphocytic leukemia (B-CLL) are clonal populations of mlgM+ or mlgM+/mlgD+ CD5' B cells that appear to be arrested in the follicular mantle-zone B-cell stage. Functional analyses have shown two groups of B-CLL that can be distinguished based on their capacity to proliferate in response to B-cell antigen receptor complex (BCRI crosslinking. To investigate the molecular basis for this phenomenon, we have analyzed both architecture and functional properties of BCR complexes on these two groups of B-CLL. Both groups were found to express structurally similar BCR. However, protein tyrosine kinase (PTK) activity associated with and specific for BCR constituents was strongly diminished in nonresponsive B-CLL. Moreover, the PTK-dependent
Tolerant autoreactive murine B cells are characterized by a specific inability to respond to BCR l i g a t i~n .~~, '~ Apparently, (auto)antigen recognition by these cells, which phenotypically resemble follicular mantle-zone B cells, has modified the capacity to translate BCR ligation in cellular activation. Recently, this functional silencing upon (auto)antigen encounter was found to correlate with a severely impaired BCR-mediated FTK a~tivation.~" B chronic lymphocytic leukemia (B-CLL) are clonal populations of mIgM+ or mIgM+/mIgD+ CD5+ B cells that appear to be arrested in a differentiation stage phenotypically resembling follicular mantle-zone B cells. Functional analysis of distinct B-CLL populations has shown an interesting dichotomy regarding their ability to respond to BCR ligation with both intracellular calcium ([Ca"],) increases and mitogenic responses. This distinct behavior could not be explained by differences in mIg expression and could be overcome by signals that bypass the BCR."'4 The apparent functional and phenotypic similarity to murine tolerant B cells suggested to us that B-CLL may be used as a human equivalent to study BCR nonresponsiveness. Therefore, to further analyze the molecular basis for these signaling defects, we have compared both structural and functional characteristics of the BCR in the two groups of B-CLL.
Immunojluorescence analyses. Cells were stained with p or 6 heavy chain MoAb. Subsequently these cells were incubated with HTC-labeled goat-antimouse Ig and analyzed on a FACScan (Becton Dickinson).
Measurement of [Caz+li, Purified lymphocytes were loaded with Indo-l-AM (1 pmol/L; Molecular Probes, Eugene, OR) for 60 minutes at 37°C in HEPES medium as described p r e v i o~s l y .~~ [Ca"], concentrations were determined on a Shimadzu spectrofluorometer and calculated as described elsewhere. 36 Statistical analysis. The correlation between B-cell proliferation and increases in [Ca2+Ii was determined with the Fisher exact test.
Biochemical Analyses
Radiolabeling. For cell surface radioiodination, 20 X lo6 viable cells were suspended in phosphate-buffered saline and labeled with 1 to 2 mCi Na IZI (Amersham CO, Amersham, UK) and lactoperoxidase as a catalyst.
Immunoprecipitation. Labeled or unlabeled cells were washed three times in serum-free medium and lysed in immunoprecipitation buffer (IPB), consisting of 0.01 m o a triethanolamine-HCl, pH 7.8, 0.15 m o m NaCl, 5 mmolL EDTA, 1 mmom l-chloro-3-tosylamido-7-amino-2-heptanone hydrochloride, 0.02 mg/mL ovomucoid trypsin inhibitor, 1 mmol/L phenylmethylsulfonyl, 0.02 mg/mL leupeptin, supplemented with 1 % digitonine or 1 % NP-40 as detergent. Nuclear debris was removed by centrifugation for 15 minutes at 13,000g. Lysates were precleared by four incubations with 60 pL of a 10% (volhrol) suspension of protein A-CUB Sepharose beads (Pharmacia) coated with normal mouse Ig. Specific immunoprecipitation was performed for 2 hours. Immunoprecipitates were subjected to five washes in IPB with detergent and resuspended in sample buffer.
In vitro phosphorylation assay. Immunoprecipitates from unlabeled cells were washed five times in IPB (without EDTA), and incubated with 25 @L of kinase buffer (25 mmoVL HEPES, pH 7.4, 100 mmoVL NaCI, 10 mmol/L MgC12, and 10 mmoVL MnCIZ), containing 5 to 10 pCi 32P-y adenosine triphosphate (Amersham), for IO minutes at room temperature. Subsequently, immunoprecipitates were washed once in IPB containing EDTA and suspended in sample buffer.
Gel electrophoresis of immunoprecipitates. Iodinated samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 10% polyacrylamide gels under nonreducing conditions and subsequently in 5% to 15% polyacrylamide gradient gels with a modification of the Laemmli procedure under reducing conditions (5% 2-mercaptoethanol in SDS sample buffer).
Phosphorylated samples were directly analyzed by SDS-PAGE under reducing conditions. Autoradiography took place at -70"C, using Kodak X-OMAT AR5 films (Eaastman-Kodak, Rochester, NY) in combination with intensifier screens (Cronex; DuPont CO, Wilmington, DE).
KOH treatment.
Treatment was performed as previously de-~c r i b e d .~ B-cell activation assay and Western blotting. Cells (10 to 25 X IO6) were activated and immunoprecipitates were analyzed essentially as recently described." Briefly, cells were incubated with biotinylated p or 6 heavy chain-specific MoAbs (2 to 10 pg/mL) and subsequently cross-linked with streptavidine (25 pg/mL). The reaction was stopped by addition of ice-cold NP-40 IPB. After the immunoprecipitation and 10% SDS-PAGE, proteins were transfered to Hybond C nitrocellulose membranes (Amersham, UK) and, after blocking with 1% bovine serum albumin, reactivity with specific antibodies was detected by chemiluminescence (ECL; Amersham, Amersham, UK) to visualize the bound proteins. For the analyses of the FTK and protein tyrosine phosphatase ( R P ) protein expression NP-40 lysates of 4 X l@ cell equivalents were separated by 8% SDS-PAGE and analyzed as described above. Autoradiography was performed with Kodak X-OMAT S films.
B-cell proliferation assays. Purified 
RESULTS

Distinct BCR-Mediated Proliferative Responses of B-CLL Cells
From a panel of 31 B-CLL samples, containing 21 proliferating and 10 nonproliferating B-CLLs, two groups of eight B-CLL were selected based on their distinct capacity to proliferate upon BCR ligation (Table 1 ). In both groups, seven of eight B-CLLs were mIgM+/mIgD+ and 1 of 8 was mIgM'. However, a certain degree of heterogeneity in mIg expression was observed in each group as shown in Table 1 . In agreement with previous report^,^'.^^ the distinct proliferative responses could not be explained by the levels of mIg expression. In accordance with previous findings, the BCR-induced proliferative responses were found to correlate with the capacity to mobilize intracellular Ca" in almost all cases (Table l; P < .01).32.33 Together, these observations strongly suggest that BCR signaling is interrupted at an early stage, and, therefore, we decided to analyze the architecture and function of BCR complexes on these distinct groups of B-CLL.
Functionally Distinct B-CLLs Express Structurally Similar Antigen Receptors
To study the composition of antigen receptor complexes on both B-CLL groups, mIgM and mIgD complexes were isolated from surface-iodinated B-CLL cells with p or S heavy chain-specific MoAb, respectively, and separated by SDS-PAGE under nonreducing conditions in the first and under reducing conditions in the second dimension (Fig 1) . In mIgM and mIgD complexes derived from both nonrespon- sive and responsive B-CLL cells, two heterodimers could be discerned that migrated below the diagonal. These heterodimers represent the mIg H and L chains, and the Iga and Igp proteins, respectively. The differences in labeling intensity between the Iga and Igp proteins both within a single immunoprecipitate and when comparing mIgM and mIgD complexes is in accordance with our previous observations?" In addition to these two heterodimers, an additional protein with an apparent molecular weight of 65 to 68 kD that migrated on the diagonal could be detected. This protein, which was more easily visualized in mIgD complexes, most probably represents CD5. 39 Together these data show that structurally similar antigen receptor complexes are expressed on these two groups of functionally distinct B-CLL.
Differences in BCR-Associated Protein (Tyrosine) Kinase Activity
We and others have previously shown that the BCR on normal human B-cells is associated with P(T)K activity and that the cytoplasmic tails of both Iga and Igp may serve as substrate for this a~t i v i t y .~.~ To analyze whether the two groups of B-CLL differ in this respect, mIgM and mIgD complexes were isolated from B-CLL cells, subsequently phosphorylated in vitro and separated by SDS-PAGE under reducing conditions. Two representative B-CLL from both the responsive (I) and the nonresponsive ( For personal use only. on October 27, 2017. by guest www.bloodjournal.org From in antiphosphotyrosine immunoblots of cell lysates. Upon BCR ligation. tyrosine phosphorylation of cellular proteins could be easily detected in cell lysates from responsive B-CLL. However, activation-induced tyrosine phosphoproteins were hardly detected or absent in nonresponsive B-CLLs (Fig 3) . Phosphorylation of tyrosine residues in the cytoplasmic tail of both Igcr and lgp has been reported to be of critical importance for BCR signaling.'"~'" To analyze BCR-induced tyrosine phosphorylation of the Igc~/lgfl heterodimer. the heterodimer was isolated with Iga-specific MoAb, separated by SDS-PAGE under nonreducing conditions and analyzed in antiphosphotyrosine blots. 
As shown in
Defective RCR-Induced Tvrosine Phosphor?.lntion Prevents Assemhly o f the Sltc/GrhZ Complex
Tyrosine phosphorylation is an early and critical event in the recruitment and induction of catalytic activities involved
B-CLL Subgroups Differ in rhe Expression of the PTK syk
Several studies have indicated that the expression levels of PTK and PTP may affect the functional properties of the BCR and other surface receptors. Absence of the PTK lyn or syk has been shown to invalidate BCR ~i g n a l i n g~'~~~ and overexpression of the PTP hcp was found to down-regulate interleukin-3 receptor signaling." Therefore, we analyzed whether the BCR nonresponsiveness is correlated with ex- similar levels in both groups of B-CLL (Fig 6 and data not  shown) . However, a clear difference was observed in the expression of PTK syk that was considerably lower in the nonresponsive B-CLL (Fig 6, upper panel) . Densitometric analyses indicated that the syk expression was threefold to ninefold lower in this group.
DISCUSSION
We here show that ligation of structurally similar antigen receptor complexes on two groups of B-CLL results in the For personal use only. on October 27, 2017. by guest www.bloodjournal.org From induction of distinct intracellular responses, which lead to entry into the cell cycle in one group of B-CLL, but which apparently have no effect on B-CLL belonging to the second group of B-CLL. Biochemical analysis showed decreased levels of BCR-associated PTK activity in nonresponsive B-CLL compared with responsive B-CLL, accompanied by a largely diminished or total lack of induction of Igcyngp tyrosine phosphorylation. The defective activation of FTK upon BCR ligation prevented the assembly of a multimeric Shc complex that may normally couple the BCR to the mitogenic ~2 1 "~ p a t h~a y .~~, " ,~~ Finally, we provide evidence that considerably lower levels of the PTK syk are expressed in the nonresponsive B-CLL. These data suggest that BCR nonresponsiveness in particular B-CLL may be caused by a decreased expression of the PTK syk. Although the phosphorylation status of the syk protein after activation has not been directly addressed, our findings seem to be in agreement with its proposed proximal position in the BCR signaling ~ascade.'~ The absence of BCR-induced Ca" mobilization and phospholipase C-y, tyrosine phosphorylation in syk-deficient B cells," together with the recently reported correlation between the inability of B-CLL cells to mobilize intracellular Ca2+ and the absence of BCR-induced PLC-y, tyrosine pho~phorylation,~~ further support this hypothesis. A number of reports have shown the essential contribution of the IgaAgp heterodimer in BCR signaling. Mutated or chimeric mIg molecules that were expressed in the absence of the Igangp sheath displayed defective signaling capac-In addition, studies with chimeric transmembrane molecules incorporating the cytoplasmic domain of Iga or Igp have provided clear evidence for their signaling potena single copy of the antigen receptor homology 1 motif:' and recently evidence has been provided that phosphorylation of the tyrosine residues in this motif is involved in both the SH2 domain-mediated binding and activation of src-family PTK.14.47 Our observation that defective BCR-induced PTK activation is accompanied by largely diminished or nonexistent IgcyAgp tyrosine phosphorylation appears concordant with these findings.
The question can be raised whether the BCR nonresponsiveness has a structural or regulatory basis. Several genetically encoded defects have been reported to result in severely impaired or lack of BCR signaling. Recent studies in Zynand syk-deficient B cells have clearly shown the critical role of both PTK in BCR signaling.53354 These distinct PTK are normally activated upon BCR ligation2L~23~24.26~63 and, although their in vivo substrates remain to be identified, they probably cooperate in BCR signaling." In addition, deficient expression of the PTP CD45 was found to interfere with the BCR signaling capacity.62 Thus far, these genetic defects resulting in impaired BCR signaling have only been described in manipulated B-cell lines. However, as with various other types of human leukemia, several chromosomal abnormalities have been reported in B-CLL. The most frequent abnormality, representing one third of cases, concerns trisomy 12.65.66 In addition, structural aberrations affecting 13q14 or 14q32 have been described in B-CLL.M49 Interestingly, each of these subgroups was found to correlate differ-tial.ll-16 Both the Iga and Igp cytoplasmic tails incorporate ently with clinical disease progression.66 However, at present the molecular mechanism responsible for these in vivo differences in clinical behavior is unknown. Moreover, because karyotypic data were not available in our study, a possible correlation with our in vitro observations could not be ana-In contrast with a primary structural defect, acquired regulatory defects could be responsible for impaired BCR signaling. Recently, such a regulatory defect in BCR signaling has been reported in tolerant murine autoreactive B cells. In double transgenic mice, autoantigen encounter by B cells was found to induce a selective modification in the functional properties of the BCR. As a result, tolerant B cells appeared refractory in BCR-induced proliferation, mobilization of intracellular Ca2+ and activation of PTK.30 Notably, comparable findings were obtained in T-cell receptor transgenic mice upon self-superantigen encounter and in T-cell hybridomas after prolonged T-cell receptor ligati~n.~"~' These observations indicate that autoreactive lymphocytes can be inactivated via antigen-mediated down-regulation of antigen receptor-associated PTK activity. Whether this directly affects the BCR-associated PTK or their regulation by other proteins (eg, PTK or PTP) in these autoreactive B cells remains to be established. In any case, based on our present findings, it will be interesting to analyze the expression level of PTKs (in particular PTK syk) in these B cells. These observations raise the interesting possibility that nonresponsive B-CLLs may represent a malignant equivalent of tolerant follicular mantle-zone B cells, whereas responsive B-CLL may represent the nontolerant counterpart. Another possibility could be that B-CLLs initially originate from follicular mantle-zone B cells, but that the transforming events determine the functional behavior. The role of antigen specificity in pathogenesis and clinical course of B-CLL is still a matter of debate." However, the recently reported correlation between BCR-mediated mitogenic response of B-CLL cells in vitro and clinical disease progression may be in favor for such a role. 73 In view of these possibilities it will be informative to relate the distinct in vitro responses with the in vivo characteristics of B-CLL.
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